Dadha Pharma prioritizes innovative drug delivery systems, focusing on enhancing bioavailability and patient compliance. Current projects include developing novel formulations for existing medications using nanotechnology and liposomal encapsulation.
Significant investment supports research into herbal formulations, exploring the therapeutic potential of traditional Indian medicine. This involves rigorous scientific validation and standardization of herbal extracts. Specific focus areas include anti-inflammatory and anti-diabetic compounds.
Dadha Pharma collaborates extensively with academic institutions and research organizations. These partnerships facilitate access to cutting-edge technologies and expertise, driving the development of new drug candidates and improved manufacturing processes. A key partnership with the Indian Institute of Technology (IIT) Bombay is currently exploring targeted drug delivery for cancer treatments.
The company maintains a robust intellectual property portfolio, actively pursuing patents for its innovative formulations and technologies. This protects its investment in R&D and ensures competitive advantage in the pharmaceutical market. Over 15 patent applications are currently pending.
Dadha Pharma’s commitment to R&D is reflected in its dedicated team of scientists and engineers. The company invests heavily in employee training and development, ensuring that its R&D capabilities remain at the forefront of the pharmaceutical industry. Recent initiatives include sending team members to advanced training programs in Switzerland.
